|
||||||
An old drug with new tricks...Researchers now believe a diabetes drug may also aid in weight loss.
If you have a body mass index of more than 30, you are obese. And help may be on the way. Pramlintide, sold in the U.S. under the trade name Symlin, is a synthetic version of a natural hormone called amylin. This hormone is now used to lower blood sugar in diabetes patients. But it also works to slow down gastric emptying, making you feel full sooner. A new study involving 204 people with a body mass index of 37.8 were randomly assigned either pramlintide or a placebo. After 16 weeks, the participants who took the drug lost 3.7 kilograms of body weight and saw a 3.6 centimeter drop in waist circumference. About 31 percent of the pramlintide treatment group achieved a weight loss of 5 percent or more, compared to only 2 percent of the placebo patients. The senior investigator of this study, Dr. Christian Weyer of Amylin Pharmaceuticals, is optimistic about the findings. "Further evaluation of pramlintide as a potential treatment for obesity is warranted." He adds, "Several clinical studies are currently underway, in which pramlintide is being evaluated in combination therapy, either with approved oral weight loss medications or with other neurohormones." Although preliminary studies appear hopeful, drugs are still not a substitute for diet and exercise. Obesity now accounts for 123 billion dollars in health care costs annually. The Cleveland Clinic is beginning what it calls a "fight back against obesity," by urging people to M.O.V.E:
The benefits of exercise are huge:
If these reasons don’t get you up and moving, maybe the lure of fitting into those new fall fashions will! Sources: Reuters Health, Cleveland Clinic
The copyright of the article New Weight Loss Drug in Women’s Health is owned by L. Marie Dubuque. Permission to republish New Weight Loss Drug in print or online must be granted by the author in writing.
|
||||||
|
|
||||||
|
|
||||||